One longitudinal study found that persons with SLE with at least one negative ANA over the first 5 years of disease had features suggestive of milder disease, with lower activity scores (by SLEDAI-2 K) and fewer autoantibodies to specific antigens compared to patients with persistently positive ANAs (15). The gene discussed is BTG3; the disease is systemic lupus erythematosus.